Yuhan Corporation (000105.KS)
000105.KS Stock Price Chart
Explore Yuhan Corporation interactive price chart. Choose custom timeframes to analyze 000105.KS price movements and trends.
000105.KS Company Profile
Discover essential business fundamentals and corporate details for Yuhan Corporation (000105.KS) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
29 Sept 2005
Employees
2.00K
Website
https://www.yuhan.co.krCEO
Wook-Je Cho
Description
Yuhan Corporation, a pharmaceutical company, engages in the research, development, and production of active pharmaceutical products and intermediates in South Korea and internationally. It offers antivirals, antibiotics, antihistamines, antidiabetics, beta-lactamase inhibitors, CNS intermediates, and PEGylated compounds; Revanex, an acid pump antagonist for the treatment of peptic ulcers and gastritis-related mucosal injury; ETC products in the areas of cardiovascular, alimentary, genito-urinary, metabolic, respiratory and allergy, and neuro systems; anti-infective, anti-cancer, and hormone and other products; and analgesics, anti-rheumatics, and anesthetics. It also offers OTC products, including vitamins and minerals, hepatopathy drugs and tonics, respiratory system drugs, alimentary system drugs, dermatology and analgesics drugs, and others; and household and healthcare products, such as bleaches, detergents, pesticides, and oral care products. In addition, the company engages in dental business and offers implants, dental equipment/consumable, and dental care products. Additionally, the company manufactures and sells medical supplies for livestock, aquatic animals, and household pets. Further, it provides contract manufacturing services. Yuhan Corporation was founded in 1926 and is headquartered in Seoul, South Korea.
000105.KS Financial Timeline
Browse a chronological timeline of Yuhan Corporation corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 6 May 2026
Upcoming earnings on 10 Feb 2026
Upcoming earnings on 27 Oct 2025
Earnings released on 30 Jul 2025
Revenue for the quarter reached ₩578.99B , missing expectations by -4.29%.
Earnings released on 8 May 2025
EPS came in at ₩118.00 falling short of the estimated ₩118.52 by -0.44%, while revenue for the quarter reached ₩491.56B , missing expectations by -4.86%.
Earnings released on 12 Feb 2025
EPS came in at -₩153.53 falling short of the estimated ₩320.35 by -147.92%, while revenue for the quarter reached ₩496.10B , missing expectations by -2.11%.
Dividend declared on 27 Dec 2024
A dividend of ₩510.00 per share was announced, adjusted to ₩510.00. The dividend was paid on 1 Mar 2025.
Earnings released on 28 Oct 2024
EPS came in at ₩499.00 falling short of the estimated ₩773.23 by -35.47%, while revenue for the quarter reached ₩598.78B , beating expectations by +12.66%.
Earnings released on 30 Jul 2024
EPS came in at ₩427.81 surpassing the estimated ₩391.94 by +9.15%, while revenue for the quarter reached ₩528.31B , beating expectations by +0.90%.
Earnings released on 30 Apr 2024
EPS came in at ₩169.61 falling short of the estimated ₩303.89 by -44.19%, while revenue for the quarter reached ₩444.59B , missing expectations by -4.24%.
Earnings released on 15 Mar 2024
EPS came in at ₩1.24K surpassing the estimated ₩31.44 by +3.83K%, while revenue for the quarter reached ₩437.15B , missing expectations by -8.86%.
Dividend declared on 27 Dec 2023
A dividend of ₩460.00 per share was announced, adjusted to ₩460.00. The dividend was paid on 29 Mar 2024.
Earnings released on 30 Sept 2023
EPS came in at ₩260.95 falling short of the estimated ₩280.59 by -7.00%, while revenue for the quarter reached ₩483.06B , beating expectations by +1.79%.
Earnings released on 30 Jun 2023
EPS came in at ₩115.74 falling short of the estimated ₩354.87 by -67.39%, while revenue for the quarter reached ₩495.72B , missing expectations by -1.87%.
Earnings released on 31 Mar 2023
EPS came in at ₩296.58 surpassing the estimated ₩280.16 by +5.86%, while revenue for the quarter reached ₩443.05B , missing expectations by -0.30%.
Earnings released on 31 Dec 2022
EPS came in at ₩500.92 surpassing the estimated ₩428.45 by +16.91%, while revenue for the quarter reached ₩450.50B , beating expectations by +0.08%.
Dividend declared on 28 Dec 2022
A dividend of ₩410.00 per share was announced, adjusted to ₩410.00. The dividend was paid on 6 Apr 2023.
Earnings released on 30 Sept 2022
EPS came in at ₩77.11 falling short of the estimated ₩598.80 by -87.12%, while revenue for the quarter reached ₩431.54B , missing expectations by -2.48%.
Earnings released on 30 Jun 2022
EPS came in at ₩475.24 surpassing the estimated ₩401.02 by +18.51%, while revenue for the quarter reached ₩482.95B , beating expectations by +1.86%.
Earnings released on 31 Mar 2022
EPS came in at ₩222.86 surpassing the estimated ₩198.98 by +12.00%, while revenue for the quarter reached ₩410.85B , missing expectations by -0.63%.
Earnings released on 31 Dec 2021
EPS came in at ₩262.28 , while revenue for the quarter reached ₩423.97B .
Dividend declared on 29 Dec 2021
A dividend of ₩410.00 per share was announced, adjusted to ₩410.00. The dividend was paid on 1 Apr 2022.
Earnings released on 30 Sept 2021
EPS came in at ₩317.46 falling short of the estimated ₩603.00 by -47.35%, while revenue for the quarter reached ₩451.47B , beating expectations by +2.75%.
Earnings released on 30 Jun 2021
EPS came in at ₩450.79 , while revenue for the quarter reached ₩433.34B .
Earnings released on 31 Mar 2021
EPS came in at ₩272.11 , while revenue for the quarter reached ₩379.03B .
Earnings released on 31 Dec 2020
EPS came in at ₩193.78 , while revenue for the quarter reached ₩461.42B .
Dividend declared on 29 Dec 2020
A dividend of ₩410.00 per share was announced, adjusted to ₩410.00. The dividend was paid on 2 Apr 2021.
Earnings released on 30 Sept 2020
EPS came in at ₩400.82 , while revenue for the quarter reached ₩429.68B .
000105.KS Stock Performance
Access detailed 000105.KS performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.